Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pyxis Oncology, Inc. (NASDAQ: PYXS)

 
PYXS Technical Analysis
5
As on 21st Nov 2024 PYXS STOCK Price closed @ 2.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.98 & Strong Sell for SHORT-TERM with Stoploss of 2.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PYXSSTOCK Price

Open 2.17 Change Price %
High 2.39 1 Day -2.06 -49.52
Low 1.90 1 Week -2.64 -55.70
Close 2.10 1 Month -1.21 -36.56
Volume 15104395 1 Year -0.87 -29.29
52 Week High 6.59 | 52 Week Low 1.40
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 146.67 0.53%
AKTS 0.10 11.11%
WORX 2.12 116.33%
QUBT 4.76 29.35%
LMDX 0.02 0.00%
SMCI 29.70 5.06%
MSTR 397.28 -16.16%
MARA 23.81 22.17%
CRNC 5.83 106.74%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
LAZR 10.24 1164.20%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
FBRX 15.64 163.74%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
PRFX 3.10 131.34%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
ZVZZT 11.30 -64.82%
MILEW 0.06 -53.85%
MNTSW 0.01 -50.00%
LOTZW 0.01 -50.00%
LIXTW 0.02 -50.00%
 
 
PYXS
Daily Charts		 PYXS
Intraday Charts		 Whats New @
Bazaartrend		 PYXS
Free Analysis
 
PYXS Important Levels Intraday
RESISTANCE3.04
RESISTANCE2.74
RESISTANCE2.55
RESISTANCE2.37
SUPPORT1.83
SUPPORT1.65
SUPPORT1.46
SUPPORT1.16
 
PYXS Forecast November 2024
Share
4th UP Forecast3.6
3rd UP Forecast3.12
2nd UP Forecast2.82
1st UP Forecast2.53
1st DOWN Forecast1.67
2nd DOWN Forecast1.38
3rd DOWN Forecast1.08
4th DOWN Forecast0.6
 
PYXS Weekly Forecast
4th UP Forecast3.24
3rd UP Forecast2.87
2nd UP Forecast2.65
1st UP Forecast2.42
1st DOWN Forecast1.78
2nd DOWN Forecast1.55
3rd DOWN Forecast1.33
4th DOWN Forecast0.96
 
PYXS Forecast2024
4th UP Forecast12.7
3rd UP Forecast9.3
2nd UP Forecast7.2
1st UP Forecast5.1
1st DOWN Forecast-0.9
2nd DOWN Forecast-3
3rd DOWN Forecast-5.1
4th DOWN Forecast-8.5
 
 
PYXS Other Details
Segment EQ
Market Capital 423689216.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PYXS Address
PYXS
 
PYXS Latest News
 
Your Comments and Response on Pyxis Oncology, Inc.
 
PYXS Business Profile
Pyxis Oncology, Inc., a preclinical stage biotechnology company, engages in the development of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies to treat cancers. Its preclinical products pipeline includes PYX-201, a site-specific investigational ADC targeting onco-fetal fibronectin extradomain-B for the treatment of non-small cell lung cancer; PYX-202, a site-specific investigational ADC targeting delta like non-canonical notch ligand 1 to treat small cell lung cancer, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational site-specific ADC targeting CD123 for the treatment of acute myeloid leukemia and other blood cancers. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service